# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, Paragraph 2: Amendment of the Access to Medical Treatments (Innovation) Act 2016


In section 3(2)(b) and (4)(a), (b) and (c) of the Access to Medical Treatments (Innovation) Act 2016 (provision supplementary to section 2: database of innovative treatments) insert “UK” before “marketing authorisation”.

---
Source: https://www.legislation.gov.uk/ukdsi/2019/9780111179185/schedule/8/paragraph/2 (the official version)
Page: https://openlegislation.uk/draft-human-medicines-amendment-etc-eu-exit-regulations-2019/schedule-8/paragraph-2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.